IRIS UniCatt

Gentile, Marino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 867
AS - Asia 691
EU - Europa 528
SA - Sud America 165
AF - Africa 20
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 2.278
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 835
SG - Singapore 382
SE - Svezia 170
BR - Brasile 137
CN - Cina 99
IT - Italia 84
FR - Francia 63
DE - Germania 62
IN - India 57
IE - Irlanda 42
VN - Vietnam 41
GB - Regno Unito 34
ID - Indonesia 25
CA - Canada 15
AR - Argentina 12
MX - Messico 12
BD - Bangladesh 11
AT - Austria 10
HK - Hong Kong 10
RU - Federazione Russa 10
TR - Turchia 10
ZA - Sudafrica 10
FI - Finlandia 9
JP - Giappone 7
KR - Corea 7
LT - Lituania 7
PK - Pakistan 7
PL - Polonia 7
UA - Ucraina 6
IQ - Iraq 5
JO - Giordania 5
UZ - Uzbekistan 5
VE - Venezuela 5
AU - Australia 4
MA - Marocco 4
NL - Olanda 4
BE - Belgio 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
ES - Italia 3
GR - Grecia 3
SA - Arabia Saudita 3
BO - Bolivia 2
CH - Svizzera 2
CO - Colombia 2
DZ - Algeria 2
ET - Etiopia 2
GE - Georgia 2
KZ - Kazakistan 2
LV - Lettonia 2
MY - Malesia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CL - Cile 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
EG - Egitto 1
EU - Europa 1
IR - Iran 1
KE - Kenya 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 2.278
Salva come PNG Salva come JPEG
Città #
Singapore 227
Chandler 183
Ashburn 81
New York 54
San Jose 35
Dublin 34
Los Angeles 31
Beijing 29
Hyderabad 29
Frankfurt am Main 23
Jakarta 23
Dallas 22
Princeton 21
Milan 18
San Mateo 16
Ho Chi Minh City 15
São Paulo 15
Wilmington 15
Marseille 13
Düsseldorf 12
Florence 12
Hefei 12
Lauterbourg 12
Dearborn 9
Houston 9
London 9
Pune 9
Boston 8
Hanoi 8
Helsinki 8
Hong Kong 8
Nuremberg 8
Johannesburg 7
Norwalk 7
Rio de Janeiro 7
Seoul 7
Tokyo 7
Trieste 7
Brooklyn 6
Garden City 6
Moscow 6
Poplar 6
Amman 5
Atlanta 5
Chicago 5
Columbus 5
Fairfield 5
Redwood City 5
Stockholm 5
Tashkent 5
Toronto 5
Ankara 4
Belo Horizonte 4
Benalla 4
Bologna 4
Cattolica 4
Chennai 4
Denver 4
Jacksonville 4
Lahore 4
Munich 4
Phoenix 4
Querétaro 4
Redmond 4
Seattle 4
The Dalles 4
Vicopisano 4
Washington 4
Baghdad 3
Bremen 3
Brussels 3
Campinas 3
City of London 3
Falls Church 3
Fremont 3
Genoa 3
Haiphong 3
Izmir 3
Manchester 3
Montreal 3
Orem 3
Passo Fundo 3
Portsmouth 3
Salvador 3
San Francisco 3
Wroclaw 3
Addis Ababa 2
Andover 2
Bari 2
Brno 2
Buenos Aires 2
Caxias do Sul 2
Central 2
Chengdu 2
Cleveland 2
Colombo 2
Dhaka 2
Feira de Santana 2
Fortaleza 2
Guayaquil 2
Totale 1.269
Salva come PNG Salva come JPEG
Nome #
Adult phenotype in Koolen-de Vries/KANSL1 haploinsufficiency syndrome 178
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs 140
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases 135
Clinical Features of Patients with Cervical Artery Dissection and Fibromuscular Dysplasia 125
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 112
Prognostic impact and risk factors of infections in patients with chronic lymphocytic leukemia treated with ibrutinib 108
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study 108
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study 98
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study 96
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group 96
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies 95
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials 94
Combining PARP inhibition and immune checkpoint blockade in ovarian cancer patients: a new perspective on the horizon? 92
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death 92
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group 89
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases 88
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL 86
CD49d promotes disease progression in chronic lymphocytic leukemia: New insights from CD49d bimodal expression 83
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus 80
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report 80
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab 79
Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: A Campus CLL report 77
Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice. 73
Totale 2.304
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.598
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.598
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202122 0 0 0 0 0 0 9 0 1 9 1 2
2021/2022233 5 0 49 32 27 5 2 26 7 7 48 25
2022/2023422 58 67 30 64 18 66 15 25 55 3 12 9
2023/2024243 9 59 11 12 15 59 14 12 1 8 14 29
2024/2025472 9 13 31 19 43 20 19 15 57 96 89 61
2025/2026873 200 37 69 162 245 69 91 0 0 0 0 0
Totale 2.304